
Atomic Show #314 – Economies of scale for micro, small, medium, large reactors – with James Krellenstein
James Krellenstein is a physicist, consultant and nuclear energy historian. He is currently employed as a senior advisor to Global Health Strategies. He started up their decarbonization practice with an emphasis on nuclear energy along with renewables. He was the lead author on GEH’s report on ways to reduce global dependence on Russia for necessary…

Why did the Carbon Free Power Project get cancelled? What does that mean for NuScale?
I’ll start with a disclosure. I’m still long on NuScale in my personal portfolio and have no intention of changing that position in the near future. I believe that the company has a…

Atomic Show #313 – Stefano Buono, Founder and CEO of Newcleo
Stefano Buono is a physicist and the successful founder of Advanced Accelerator Applications, a multibillion dollar company that pioneered the use of several therapeutic medical isotopes. After making several people very rich, including…

Parnassus Versus Green Century: A Contrast in Styles
Cross-posted from Nucleation Capital June, July and August of 2023 were the three hottest months the Earth has ever seen by such a large margin, it left climate scientists agog. Climate disasters are…

Unnecessary rules should be eliminated
Commissioners on the Nuclear Regulatory Commission are worried. They see a pending avalanche of license applications for new reactors, fuel production facilities, uranium mines, transportation containers, and waste repositories with an insufficiently sized…

Atomic Show #314 – Economies of scale for micro, small, medium, large reactors – with James Krellenstein
James Krellenstein is a physicist, consultant and nuclear energy historian. He is currently employed as a senior advisor to Global Health Strategies. He started up their decarbonization practice with an emphasis on nuclear…

Atomic Show #313 – Stefano Buono, Founder and CEO of Newcleo
Stefano Buono is a physicist and the successful founder of Advanced Accelerator Applications, a multibillion dollar company that pioneered the use of several therapeutic medical isotopes. After making several people very rich, including…

Atomic Show #312 – Tyler Bernstein, CEO Zeno Power
Zeno Power makes cost-effective radioisotope power systems (RPS) for some of the most challenging environments in the solar system. Its systems use a proprietary package that allows a wider variety of isotopes to…
NuScale and DOE finalize the agreement announced six months ago
On December 12, 2013, the US Department of Energy announced that it had selected NuScale as the winner of a cost share program to develop small modular reactors. This morning, NuScale distributed the…
NuScale wins second round of DOE SMR funding under FOA
On December 12, 2013, the US Department of Energy (DOE) announced the selection of NuScale as the winner of the second round of funding under the Department of Energy Funding Opportunity Announcement (FOA)….
DOE and UAMPS sign agreement for siting at INL
At the 12th annual Platts Nuclear Energy Conference, John Kotek, the Acting Assistant Secretary of Energy for Nuclear Energy just made a major announcement. Yesterday, February 17, 2016 Rick Provencher and Doug Hunter…
Irish people should ignore Arnie Gundersen because he’s wrong
A friend who often gets involved in discussions about nuclear energy stories with frightened people in his social media network contacted me to find out what I thought of an article titled Nuclear…
Georgia residents may pay for Jaczko’s antinuclear behavior
The flagship project of the US nuclear energy renaissance is in trouble. The people of the great state of Georgia and the investors in Georgia Power may end up footing the bill for…
Crowd sourced debunking of Gundersen lies about AP1000 & Fukushima
I have an important request for Atomic Insights readers. Our old friend, Arnie Gundersen, has once again violated the admonition that it is better to remain silent and thought to be a fool…
Smoking Gun Part 14 – Peter Hartley Claims Natural Gas is Cheaper Than Nuclear
Eric Berger, writing for the Houston Chronicle, published an article on Friday titled Nuclear power’s core of support gains strength. He provided some opposing view commentary from Peter Hartley, a man he describes…

How did an oil shale investor hamstring his atomic energy competition? (Ancient but impactful smoking gun)
During the contentious effort that resulted in passage of the Atomic Energy Act of 1946, Sen Eugene D. Milliken (R-CO) played an important role in establishing an attempted US government monopoly over all…
Smoking Gun Part 9 – Carbon Sequestration advocates share an interesting funding source
A good friend sent me a link to an interesting diary on Daily Kos titled “Clean Coal”‘s Dirty Hands?. That diary entry used an article written by Peter Montague, titled INSIGHTS: Carbon Sequestration…
Investing in Nuclear
Nuclear investments – enabling the transition to a low-carbon economy

Parnassus Versus Green Century: A Contrast in Styles
Cross-posted from Nucleation Capital June, July and August of 2023 were the three hottest months the Earth has ever seen by such a large margin, it left climate scientists agog. Climate disasters are abounding apace, with the U.S. hit by 23 large-scale disasters, a record-breaking year already. In Pakistan, extreme rainfall and flooding affected 33…

How Hot is Cold Fusion?
The 24th International Conference on Cold Fusion (ICCF24) was held at the lovely and spacious Computer History Museum in Mountain View, CA over four days in late July. As a venture investor looking at evaluating and investing in a wide range of advanced nuclear ventures, I was invited to participate and/or sponsor the event. While…

Rod Adams
Managing Partner, Nucleation Capital, a venture fund enabling broader investor access to a diverse portfolio of advanced nuclear energy and deep decarbonization ventures. Nuclear energy expert and former submarine Engineer Officer with nuclear propulsion plant experience. Founder, Adams Atomic Engines, Inc. Host and producer, The Atomic Show Podcast.